Lung adenocarcinoma: Are skip N2 metastases different from non-skip?
- 1 October 2015
- journal article
- research article
- Published by Elsevier in The Journal of Thoracic and Cardiovascular Surgery
- Vol. 150 (4) , 790-795
Abstract
No abstract availableKeywords
This publication has 23 references indexed in Scilit:
- The New Histologic Classification of Lung Primary Adenocarcinoma Subtypes Is a Reliable Prognostic Marker and Identifies Tumors With Different Mutation StatusChest, 2014
- Cancer StatisticsJAMA, 2013
- Frequency of well-identified oncogenic driver mutations in lung adenocarcinoma of smokers varies with histological subtypes and graduated smoking doseLung Cancer, 2013
- The IASLC Lung Cancer Staging Project: A Proposal for a New International Lymph Node Map in the Forthcoming Seventh Edition of the TNM Classification for Lung CancerJournal of Thoracic Oncology, 2009
- Analysis of risk factors for skip lymphatic metastasis and their prognostic value in operated N2 non-small-cell lung carcinomaEuropean Journal of Surgical Oncology, 2006
- Skip Mediastinal Lymph Node Metastasis and Lung Cancer: A Particular N2 Subgroup With a Better PrognosisThe Annals of Thoracic Surgery, 2005
- Skip metastases: analysis of their clinical significance and prognosis in the IIIA stage of non-small cell lung cancerEuropean Journal of Cardio-Thoracic Surgery, 2004
- Proposal for reasonable mediastinal lymphadenectomy in bronchogenic carcinomas: Role of subcarinal nodes in selective dissectionThe Journal of Thoracic and Cardiovascular Surgery, 1998
- Skip metastasis to the mediastinal lymph nodes in non-small cell lung cancerThe Annals of Thoracic Surgery, 1996
- Skip mediastinal lymph node metastasis in non‐small cell lung cancerJournal of Surgical Oncology, 1994